Recent Finacing
Recent Raise
Hinova Pharmaceuticals discovers, develops and industrializes small-molecule therapeutics for metabolic diseases and oncology, advancing a nine-candidate pipeline including HC‑1119, an androgen receptor antagonist in Phase III international trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
